A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z

Recent news on Zolpidem Tartrate


Zolpidem Tartrate Syrup (Zolpidem Tartrate capsule) Information  -  May 19, 2007
American Chronicle,Zolpidem Tartrate medication belong to Sedative and hypnotic class. Zolpidem Tartrate helps in the mechanism is unknown but may involve subunit modulation

Verispan's Vector One(R): Generic Ambien Becomes No. 1 Sleep ...  -  May 22, 2007
Genetic Engineering News (press release),Verispan's Vector One(R): National (VONA) reports zolpidem tartrate, the generic form of Ambien, has become the most prescribed drug in the sleep disorder

Verispan’s Vector One®: Generic Ambien Becomes No. 1 Sleep ...  -  May 22, 2007
Business Wire (press release),According to VONA, predictably most switching to zolpidem tartrate came from prior users of its branded equivalent and prior market leader, Ambien (87%).

Wockhardt launches insomnia drug Zolpidem in US  -  May 21, 2007
Moneycontrol.com,Zolpidem tartrate is one of the most widely used medicines to treat insomnia (sleep disorder) and is safer than most other sleeping pills in replicating

Actavis Launches Zolpidem Tablets in the US  -  Apr 27, 2007
PR-Inside.com (Pressemitteilung),Annual sales of Zolpidem Tartrate tablets in the US were approximately $2.2 billion for the twelve months ending December 2006 according to IMS Health data.

Ranbaxy gets US FDA nod for Zolpidem Tablets  -  Apr 26, 2007
Myiris.com,Zolpidem Tartrate Tablets are prescribed for the short-term treatment of insomnia, characterized by difficulty with sleep intervention.

FDA Approves First Generic Versions of Ambien for Insomnia  -  Apr 25, 2007
MedIndia,The US Food and Drug Administration (FDA) today approved the first generic versions of Ambien (zolpidem tartrate) immediate-release tablets.

Ranbaxy says gets US nod for zolpidem  -  Apr 26, 2007
Reuters India,...said on Thursday it had approval from the US Food and Drug Administration to manufacture and market zolpidem tartrate tablets, used to treat insomnia.

FDA OKs two Ranbaxy generics  -  Apr 27, 2007
Bizjournals.com,Ranbaxy will begin making Zolpidem Tartrate tablets, the generic equivalent to Sanofi Aventis US LLC's Ambien, for use in the treatment of insomnia.

Ranbaxy gets US nod for insomnia drug  -  Apr 26, 2007
Andhra Cafe,Ranbaxy Laboratories Ltd said that it had approval from the US Food and Drug Administration to manufacture and market Zolpidem Tartrate tablets,

Aurobindo gets USFDA nod for Zolpidem  -  May 7, 2007
Financial Express,Recently, Ranbaxy Laboratories and Dr Reddys Laboratories (DRL) had also received USFDA approval to manufacture and market Zolpidem Tartrate tablets in the

Business day: Bank sale blocked  -  May 4, 2007
Napa Valley Register,A patent held by Paris-based Sanofi-Aventis on the drug, also called zolpidem tartrate, expired Saturday. The approvals of generic versions of the drug come

Dr. Reddy's Announces the Launch of Zolpidem Tartrate Tablets  -  26 Apr 2007
PipelineReview.com (press release),Zolpidem Tartrate Tablets are the generic version of Sanofi-Aventis' Ambien® Tablets. Ambien Tablets had US sales of approximately $2.1 billion for the same

3 Indian firms get FDA nod for sleep disorder drug  -  26 Apr 2007
Business Standard,Zolpidem tartrate tablets are indicated for the short-term treatment of insomnia and related disorders and the drug had sales of about $ 659 million in the

FDA OKs two Ranbaxy generics  -  26 Apr 2007
Jacksonville Business Journal,Ranbaxy will begin making Zolpidem Tartrate tablets, the generic equivalent to Sanofi Aventis US LLC's Ambien, for use in the treatment of insomnia.

Roxane Laboratories, Inc. Announces Launch of Zolpidem Tartrate ...  -  Apr 23, 2007
PR-Inside.com (Pressemitteilung),Roxane Laboratories' Zolpidem Tartrate Tablets CIV, 5 mg and 10mg are AB rated to AMBIEN(R) (zolpidem tartrate) Tablets CIV, 5 mg and 10mg.

Mylan Announces Final FDA Approval and Immediate Shipment of ...  -  Apr 23, 2007
PR-Inside.com (Pressemitteilung),Zolpidem Tartrate Tablets are the generic version of Sanofi-Aventis' Ambien(R) Tablets. Ambien Tablets had US sales of approximately $2.2 billion for the

Health and Science News Roundup  -  Apr 24, 2007
Monsters and Critics.com,The immediate-release tablets of Zolpidem tartrate provide a sedative-hypnotic drug indicated for the short-term treatment of the medical condition.

Ranbaxy Receives Tentative FDA Approval to Manufacture and Market ...  -  Mar 28, 2007
Drug Newswire (press release),..."We are pleased to receive this tentative approval for Zolpidem Tartrate Tablets. This product will be launched following final approval from the FDA and

Barr challenges Sanofi's Ambien CR insomnia drug  -  Apr 9, 2007
SpiritIndia,Ambien CR (Zolpidem Tartrate Extended-Release Tablets) 6.25mg & 12.5mg is indicated for the treatment of insomnia, characterized by difficulties with sleep

Market Report -- In Play (BRL)  -  Apr 9, 2007
MSN MoneyBarr Laboratories, has initiated a patent challenge for Sanofi-Aventis's (SNY) Ambien CR (Zolpidem Tartrate Extended-Release Tablets), 6.25mg & 12.5mg.

Barr Confirms Patent Challenge of Ambien CR(R)  -  Apr 6, 2007
PR Newswire (press release),This action formally initiates the patent challenge process under the Hatch-Waxman Act. Ambien CR (Zolpidem Tartrate Extended-Release Tablets) 6.25mg

Ranbaxy gets USFDA nod for zolpidem tablet production in US  -  Mar 17, 2007
domain-B,The products will he manufactured at the Ranbaxy's Ohm Laboratories Inc. facility, based in North Brunswick, New Jersey, USA. zolpidem tartrate tablets had

RANBAXY GETS USFDA APPROVAL TO MANUFACTURE ZOLPIDEM TABS  -  Mar 19, 2007
Therapeutics Daily (subscription) (press release),In a communique to the Bombay Stock Exchange, Ranbaxy said under the USFDA approval it can manufacture and market Zolpidem Tartrate Tablets of 5mg and 10mg.

Ranbaxy receives tentative USFDA approval to manufacture and ...  -  Mar 17, 2007
Prdomain Business Register (press release),..."We are pleased to receive this tentative approval for Zolpidem Tartrate Tablets. This product will be launched following final approval from the FDA and

Ranbaxy Receives Tentative FDA Approval to Manufacture and Market ...  -  Mar 16, 2007
PR Newswire (press release),Total annual market sales for Zolpidem Tartrate Tablets were USD 2.12 Bn (IMS: Dec. 2006). Zolpidem Tartrate Tablets are indicated for the short-term

Ranbaxy Gets Tentative USFDA Nod For Zolpidem Tablets  -  Mar 16, 2007
Trading Markets,Zolpidem Tartrate tables are indicated for the short-term treatment of insomnia and related disorders. As per the IMA data published in the fourth quarter

US OKs Ranbaxy's anti-insomnia tablets  -  Mar 16, 2007
Financial Express,The company has got the approval to manufacture and market Zolpidem Tartrate tablets in multiple strengths of 5 mg and 10 mg, Ranbaxy said in a statement.

India's Ranbaxy Gets Tentative US Nod for Zolpidem  -  Mar 16, 2007
Reuters.uk,...it had received tentative approval from the US Food and Drug Administration to manufacture and market zolpidem tartrate tablets, used to treat insomnia.

US approval for Ranbaxy's insomnia drug  -  Mar 17, 2007
Andhra Cafe,The US unit of the company announced Friday that the Office of Generic Drugs, US FDA, has determined the Ranbaxy formulations of Zolpidem Tartrate tablets

Ranbaxy gets USFDA nod to sell insomnia drug  -  Mar 16, 2007
Moneycontrol.com,Ranbaxy Laboratories said on Friday it has received tentative US Food and Drug Administration's (FDA) approval to make and sell Zolpidem Tartrate tablets

Ranbaxy wins FDA nod to copy Sanofi’s Ambien  -  Mar 16, 2007
Financial Express,The Food and Drug Administration (FDA) in Washington said Ranbaxy’s tablets of zolpidem tartrate in 5 milligram and 10 milligram strengths are chemically

Ranbaxy Gets FDA Nod for $2.2B Anti-Insomnia Drug  -  Mar 16, 2007
NJBIZ,With this, Ranbaxy will be able to tap the $2.2 billion market for Zolpidem Tartrate. The FDA determined that Ranbaxy’s formulations are bioequivalent and

Ranbaxy gets US FDA approval to make generic version of Sanofi ...  -  Mar 16, 2007
Forbes,It will launch the Zolpidem Tartrate 5mg and 10mg tablets, the bio equivalent of Sanofi Aventis US, LLC's listed drug Ambien tablets 5mg and 10mg once final

Ranbaxy tentatively OK'd on generic Ambien  -  Mar 16, 2007
United Press InternationalThe Food and Drug Administration has given tentative market clearance to Ranbaxy's zolpidem tartrate tablets in 5mg and 10mg strengths.

Ranbaxy gets US FDA approval to make generic version of Sanofi ...  -  Mar 16, 2007
Euro2day,It will launch the Zolpidem Tartrate 5mg and 10mg tablets, the bio equivalent of Sanofi Aventis US, LLC''s listed drug Ambien tablets 5mg and 10mg once

Actor Cheryl Hines is Tired of Counting Sheep to Sleep ... and is ...  -  Mar 26, 2007
Drug Newswire (press release),Her healthcare professional also recommended Ambien CR(TM) (zolpidem tartrate extended-release) tablets CIV, the only controlled-release prescription sleep

Ranbaxy gets tentative FDA approval for insomnia drug  -  Mar 17, 2007
San Antonio Business Journal,Ranbaxy will market tablets of zolpidem tartrate in doses of 5 milligrams and 10 milligrams. The FDA determined that the drug is the equivalent of Ambien,

Ranbaxy Gets Tentative Ambien FDA OK  -  Mar 16, 2007
Forbes,Ranbaxy said it received the provisional Food and Drug Administration go-ahead for 5-milligram and 10-milligram tablets of zolpidem tartrate,

Ranbaxy Gets Ready to Penetrate Ambien’s $2B Market  -  Mar 16, 2007
Genetic Engineering News (press release),The Office of Generic Drugs, FDA, determined the Ranbaxy formulations of Zolpidem Tartrate tablets, 5mg and 10mg, were bioequivalent and have the same

India's main index plunges to five-month low  -  Mar 16, 2007
Gulf News,...said it had received tentative approval from the US Food and Drug Administration to make and market zolpidem tartrate tablets, used to treat insomnia.

Danish shares lower midmorning; Lundbeck, Novo Nordisk lower  -  Mar 16, 2007
Forbes,Dealers said news that Ranbaxy Laboratories has received tentative approval from the US Food and Drug Administration for its insomnia drug Zolpidem Tartrate

FDA Strengthens Warnings on Sleep Drugs  -  Mar 15, 2007
Medscape (subscription)Affected products include zolpidem tartrate tablets and extended-release tablets (Ambien and Ambien CR, Sanofi-Aventis); butisol sodium (Medpointe Pharm

Label Change Requested for All Sleep Disorder Drugs  -  Mar 14, 2007
Facts and Comparisons,The medications that are part of the revised labeling include Ambien/Ambien CR (zolpidem tartrate), Butisol Sodium (butabarbital), Dalmane (flurazepam),

Actor Cheryl Hines is Tired of Counting Sheep to Sleep... And is ...  -  Mar 10, 2007
PR.com (press release),Her healthcare professional also recommended Ambien CR (zolpidem tartrate extended-release) tablets CIV, the only controlled-release prescription sleep

Unsafe, Misrepresented Drugs Purchased Over the Internet: Ambien ...  -  Feb 19, 2007
DG NewsBETHESDA, MD -- February 19, 2007 -- FDA informed consumers and healthcare professionals regarding the possible dangers of buying prescription medications

Consumer Alert for Internet Drugs  -  Feb 22, 2007
Facts and Comparisons,Orders placed on the Internet for Ambien (zolpidem tartrate), Xanax (alprazolam), Lexapro (escitalopram oxalate), and Ativan (lorazepam) contained

Ambien, prescribed to man who killed family, linked to dangerous ...  -  Feb 21, 2007
The Journal News.com,Ambien, the commercial name for zolpidem tartrate, belongs to a class of drugs called "sedative/hypnotics." It is a fast-acting medicine used mainly for

#1 - ZOLPIDEM SIDE EFFECTS , ambien zolpidem  -  Dec 25, 2006
Indymedia Colombia,Zolpidem tartrate is zolpidem side effects that it is sibutramine 'wonder-drug', it only when needed. No Rx req Buy tramadol online!

ZOLPIDEM, buy zolpidem , buy zolpidem online , zolpidem ...  -  Dec 27, 2006
Indymedia Colombia,DRUG INTERACTIONS CNS-Active Drugs Zolpidem tartrate is buy zolpidem online informational purposes only. Zolpidem taken concurrently with Celexa.

Pharmacist struck off for theft of painkillers  -  Dec 21, 2006
This Is Lancashire,He was said to have stolen 40 Codeine Phosphate tablets and 14 Zolpidem Tartrate tablets from the Superdrug store on September 5.

#1 - ZOLPIDEM SIDE EFFECTS , ambien zolpidem  -  Dec 25, 2006
Indymedia Colombia,Zolpidem tartrate is zolpidem side effects that it is sibutramine 'wonder-drug', it only when needed. ... Zolpidem tartrate ambien, is ambien in the zoloft paper. ...

Pharmacist struck off for theft of painkillers  -  Dec 21, 2006
This Is Lancashire,He was said to have stolen 40 Codeine Phosphate tablets and 14 Zolpidem Tartrate tablets from the Superdrug store on September 5. ...

Sanofi- Aventis Receives Pediatric Exclusivity for Ambien and ...  -  Nov 30, 2006
ag-IP-news Agency,Sanofi-aventis announced on Thursday that the US Food and Drug Administration (FDA) has granted pediatric exclusivity for Ambien (zolpidem tartrate) and Ambien ...

Sanofi-Aventis Receives Pediatric Exclusivity For Ambien® And ...  -  Dec 1, 2006
Medical News Today (press release),Sanofi-aventis announced today that the US Food and Drug Administration (FDA) has granted pediatric exclusivity for Ambien® (zolpidem tartrate) and Ambien ...

NovaDel Pharma: Promising New Technology Makes It a Buy  Nov 6, 2006
If approved, Zensana could hit the market during the first half of 2007. Ambien - Zolpidem Tartrate oral spray for relief of insomnia. ... -Seeking Alpha, Sensex Keeps Momentum  Nov 6, 2006
Cipla gained 2.95% to Rs 263.50 after it received approval from the US Food and Drug administration for selling insomnia drug zolpidem tartrate in the tablet ... -123Jump.com, Sanofi-Aventis Receives Pediatric Exclusivity For Ambien® And ...  -  Dec 1, 2006
Medical News Today (press release),Sanofi-aventis announced today that the US Food and Drug Administration (FDA) has granted pediatric exclusivity for Ambien® (zolpidem tartrate) and Ambien®

Sanofi-Aventis Receives Pediatric Exclusivity for Ambien and Ambien CR  -  Nov 30, 2006
PharmaLive.com (press release),...and Drug Administration (FDA) has granted pediatric exclusivity for Ambien® (zolpidem tartrate) and Ambien® CR (zolpidem tartrate extended-release).

Sanofi- Aventis Receives Pediatric Exclusivity for Ambien and ...  -  Nov 30, 2006
ag-IP-news Agency,PARIS - Sanofi-aventis announced on Thursday that the US Food and Drug Administration (FDA) has granted pediatric exclusivity for Ambien (zolpidem tartrate)

NovaDel Announces Initiation of Clinical Trial of Zolpidem Oral ...  Aug 8, 2006
Zolpidem oral spray is NovaDel's proprietary oral spray reformulation of the sleeping medicine zolpidem tartrate. Ambien(R) (zolpidem ... -PharmaLive.com

NovaDel initiates clinical trial for insomnia spray  Aug 9, 2006
Zolpidem is the active ingredient found in the number one selling hypnotic, Ambien (zolpidem tartrate), which is marketed by Sanofi-Aventis. ... -Pharmaceutical Business Review

New Data Support Long-Term Use of Zolpidem Tartrate Extended ...  Jul 12, 2006
BRIDGEWATER, NJ -- July 12, 2006 -- Sanofi-aventis today announced results from a study that demonstrated Ambien CR (zolpidem tartrate extended release tablets ... -DG News

Chemist blames 'terrible' backache for stealing drugs  Jun 28, 2006
He was told to empty his rucksack which contained 40 Codeine Phosphate and 14 Zolpidem Tartrate tablets, the Royal Pharmaceutical Society heard. ... -ic NorthWales

(PRN) - PA State Treasurer Casey: Treasury's Investment Earnings ...  Jul 12, 2006
...[+]. (PRN) - New Data Support Long-Term Use of AMBIEN CRTM (zolpidem tartrate extended- release) Tablets C(IV) for up to 24 Weeks ... [+. ... -Bolsamania.com

New Data Support Long-Term Use Of AMBIEN CRTM (zolpidem Tartrate ...  Jul 14, 2006
Sanofi-aventis (Paris Bourse: EURONEXT: SAN; and New York: NYSE: SNY) today announced results from a study that demonstrated AMBIEN CR is well-tolerated and ... -Medical News Today

New Data Support Long-Term Use of AMBIEN CRTM (zolpidem tartrate ...  Jul 12, 2006
BRIDGEWATER, NJ, July 12 /PRNewswire-FirstCall/ -- Sanofi-aventis (Paris Bourse: EURONEXT: SAN; and New York: NYSE: SNY) today announced results from a study ... -Yahoo! News

New Data Support Long-Term Use of Ambien Crtn (zolpidem tartrate ...  Jul 12, 2006
BRIDGEWATER, NJ, July 12, 2006 /PRNewswire-FirstCall/ -- Sanofi-aventis today announced results from a study that demonstrated AMBIEN CR is well-tolerated and ... -PharmaLive.com

New Data Support Long-Term Use of AMBIEN CRTM (zolpidem tartrate ...  Jul 12, 2006
Results extending the role of AMBIEN CR in the treatment of insomnia presented at the 2006 CINP (Collegium Internationale Neuro-Psychopharmacologicum) 25th ... -PR Newswire

New Data Support Long-Term Use of AMBIEN CRTM (zolpidem tartrate ...  Jul 13, 2006
BRIDGEWATER, NJ, USA | Jul 12 2006 | Sanofi-aventis (Paris Bourse: EURONEXT: SAN; and New York: NYSE: SNY) today announced results from a study that ... -PipelineReview.com

Sepracor Announces Presentation of LUNESTA(TM) Posters at ...  Jun 21, 2006
Among study participants, the most commonly used previoustherapies were AMBIEN(R) brand zolpidem tartrate, other prescriptioninsomnia medications, and trazodone ... -Finanzen.net

Sepracor Announces Presentation of LUNESTA(TM) Posters at ...  Jun 21, 2006
Among study participants, the most commonly used previous therapies were AMBIEN(R) brand zolpidem tartrate, other prescription insomnia medications, and ... -Business Wire



sanofi-aventis reiterates safety of zolpidem tartrate CIV as ...  Apr 19, 2006
2006 APR 19 - (NewsRx.com) -- sanofi-aventis (SNY) reports that Ambien (zolpidem tartrate) CIV, when taken as directed, provides a safe and effective treatment ... - Therapeutics Daily (subscription)

There's more to falling asleep than just counting sheep  May 15, 2006
RECENT news stories about the troubles of a well-known congressman mentioned the sleep disorder drug Ambien (zolpidem tartrate). ... - Inside Bay Area

The Pill That Drove Us to Sleep  May 5, 2006
Zolpidem tartrate, the sedative-hypnotic better known to wide-awake, stressed-out sheet kickers as Ambien, is an efficacious little helper if you ever thought ... - Washington Post

Sepracor Announces First Quarter 2006 Results  Apr 25, 2006
Among study participants, the most commonly used previoustherapies were AMBIEN(R) brand zolpidem tartrate, other prescriptioninsomnia medications, and trazodone ... - Finanzen.net

Sepracor Announces First Quarter 2006 Results  Apr 25, 2006
Among study participants, the most commonly used previous therapies were AMBIEN(R) brand zolpidem tartrate, other prescription insomnia medications, and ... - Genetic Engineering News

Snooze alarm: The pill that drove us to sleep  May 6, 2006
WASHINGTON - Zolpidem tartrate, the sedative-hypnotic better known to wide-awake, stressed-out sheet kickers as Ambien, is an efficacious little helper if you ... - Standard-Speaker

New weapons in travelers' round-the-clock jet-lag fight  Apr 21, 2006
..."Ambien (zolpidem tartrate) gets you seven or eight hours of sleep," she says. "Lunesta (eszopiclone) provides seven or eight hours. ... - Los Angeles Times





Statement Responding to Recent Media Reports Regarding Appropriate ...  Mar 20, 2006
20 /PRNewswire-FirstCall/ -- Sanofi-aventis (NYSE: SNY; EURONEXT: SAN) is committed to patient health and safety and AMBIEN(R) (zolpidem tartrate) CIV -- when ... - PR Newswire

Statement Responding to Recent Media Reports Regarding Appropriate ...  Mar 20, 2006
NJ, March 20, 2006 /PRNewswire-FirstCall/ -- Sanofi-aventis is committed to patient health and safety and AMBIEN(R) (zolpidem tartrate) CIV -- when taken as ... - PharmaLive.com

(PRN) - Digital Music Group, Inc. Announces Appointment of New CFO ...  Mar 20, 2006
...[+]. (PRN) - Statement Responding to Recent Media Reports Regarding Appropriate Use of AMBIEN(R) (zolpidem tartrate) CIV in the US ... [+. ... - Bolsamania.com

Drivers Who Ought To Be In Bed  Mar 9, 2006
In press releases last year and in 2004 discussing Ambien - whose chemical name is zolpidem tartrate – Sanofi-Aventis said it is "indicated for the short ... - CBS News

FDA Issues a Written Request for Pediatric Studies for Zolpidem  Jan 11, 2006
...announced today that it has received a Written Request1 for pediatric studies from the US Food and Drug Administration (FDA) for zolpidem tartrate (AMBIENTM). ... - Biotech Intelligence

Sanofi asked by FDA for pediatric studies on Ambien insomnia ...  Jan 11, 2006
Ambien, also known as zolpidem tartrate has been approved for generic production but Sanofi last year won approval for an extended-release version of the drug. ... - Forbes

FDA Cautions Consumers Against Filling US Prescriptions Abroad  Jan 11, 2006
A supply of Amyben in place of Ambien (zolpidem tartrate), a sleeping medicine marketed in the US, could have a serious adverse outcome. ... - PharmaLive.com


This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional